Skip to main content
. 2014 Jun 28;20(24):7675–7685. doi: 10.3748/wjg.v20.i24.7675

Figure 1.

Figure 1

Role of treatment intensity and the degree of immunosuppression in hepatitis B virus reactivation during cancer therapy. The risk of hepatitis B virus (HBV) reactivation is proportionate to treatment intensity and the degree of immunosuppression.